ENVALITH
昭栄薬品株式会社 logo

SHOEI YAKUHIN CO.,LTD.

3537Standard MarketWholesale Trade

昭栄薬品株式会社 logo
SHOEI YAKUHIN CO.,LTD.3537
Reference Indicators

Market Cap

59¥100M

P/E (Forecast)

P/B

0.6x

Dividend Yield (Forecast)

2.49%

ROE

6.1%

EV/EBITDA

8.9x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
21,14724,52922,59525,01226,921
Cost of Sales
19,49722,64320,70422,91324,757
Gross Profit
1,6501,8851,8912,0992,163
SG&A Expenses
1,3481,3971,4511,5391,659
Operating Income
302488440559504
Non-operating Income
188198221206234
Non-operating Expenses
16129814
Ordinary Income
474673651757725
Extraordinary Income
370
Pre-tax Income
844673651757725
Income Taxes
266188159230168
Net Income
578484491527557
EBITDA
324502454572518
Gross Margin
7.8%7.7%8.4%8.4%8.0%
Operating Margin
1.4%2.0%1.9%2.2%1.9%
ROA
4.0%3.3%2.9%3.1%3.1%
ROE
7.9%6.8%6.3%6.2%6.1%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
化学品事業24,8996302.5%
日用品事業726496.7%
土木建設資材事業1,295-4-0.3%